About: J147     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : dbo:Drug, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FJ147&invfp=IFP_OFF&sas=SAME_AS_OFF

J147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. The approach that lead to development of the J147 drug was to screen candidate molecules for anti-aging effects, instead of targeting the amyloid plaques. It is contrary to most other approaches to developing drugs against Alzheimer's disease that target the plaque deposits in the brain. The target molecule is a protein called ATP synthase, which is found in the mitochondria.

AttributesValues
rdf:type
rdfs:label
  • J147 (en)
rdfs:comment
  • J147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. The approach that lead to development of the J147 drug was to screen candidate molecules for anti-aging effects, instead of targeting the amyloid plaques. It is contrary to most other approaches to developing drugs against Alzheimer's disease that target the plaque deposits in the brain. The target molecule is a protein called ATP synthase, which is found in the mitochondria. (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/J147_structure.png
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
sameAs
dbp:wikiPageUsesTemplate
thumbnail
c
CAS number
ChemSpiderID
F
H
IUPAC name
  • N--2,2,2-trifluoro-N-[-methylideneamino]acetamide (en)
legal US
  • Investigational New Drug (en)
n
O
PubChem
SMILES
  • CC1=CN\N=C\C2=CCOC (en)
StdInChI
StdInChIKey
  • HYMZAYGFKNNHDN-SSDVNMTOSA-N (en)
UNII
  • Z41H3C5BT9 (en)
width
has abstract
  • J147 is an experimental drug with reported effects against both Alzheimer's disease and ageing in mouse models of accelerated aging. The approach that lead to development of the J147 drug was to screen candidate molecules for anti-aging effects, instead of targeting the amyloid plaques. It is contrary to most other approaches to developing drugs against Alzheimer's disease that target the plaque deposits in the brain. The J147 drug is also reported to address other biological aging factors, such as preventing the leakage of blood from microvessels in mice brains. The development of J147 follows the chemical pharmacological way, contrary to biological ways that exploit e.g. use of bacteriophages. Its derivative CAD-31 has enhanced neurogenic activity over J147 in human neural precursor cells. CAD-31 enhances the use of free fatty acids for energy production by shifting of the metabolic profile of fatty acids toward the production of ketone bodies, a potent source of energy in the brain when glucose levels are low. The target molecule is a protein called ATP synthase, which is found in the mitochondria. (en)
gold:hypernym
prov:wasDerivedFrom
page length (characters) of wiki page
CAS number
  • (non-specific stereochemistry)
  • 1807913-16-1
FDA UNII code
  • Z41H3C5BT9
PubChem
  • 25229652
foaf:isPrimaryTopicOf
is foaf:primaryTopic of
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 67 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software